USPTO serial 79296462
TIEFENBACHER
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- REEVES, APRIL ELIZABETH
- Law office
- TMO LAW OFFICE 124 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with TIEFENBACHER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biological and biochemical products, preparations and reagents for scientific, research, laboratory and industrial purposes (other than for medical purposes); micro-organisms, proteins, polypeptides, nucleotides, nucleic acids, cell-lines and cells, in particular for scientific, research, laboratory and industrial purposes, other than for medical purposes; pharmaceutical, chemical, biological and biochemical products, preparations and reagents for researching and characterising diseases, for medical research and medicine development and for manufacturing medicines and pharmaceuticals; Chemical reagents for scientific use; biological diagnostic reagents for clinical or medical laboratory use; chemical preparations for general industrial manufacturing; Cells for scientific and research use; nucleic acid for laboratory use; biochemical, namely, polypeptides for in vitro research use; cultures of micro-organisms, other than for medical use; protein for industrial use, nucleotides for scientific and research use; Chemical additives for use in the manufacture of pharmaceuticals | ACTIVE | — |
| 005 | Medicinal specialities; generic medicines; pharmaceutical, chemical, biological and biochemical products, preparations and reagents, in particular for medical and diagnostic purposes; microorganisms, proteins, polypeptides, nucleotides, nucleic acids, cell-lines and cells, in particular for medical and diagnostic purposes, for investigation and characterisation of diseases, for medical research and development of medicines and for the manufacture of medicines and pharmaceuticals; sanitary preparations for medical purposes; dietetic preparations adapted for medical use; a full line of pharmaceuticals | ACTIVE | — |
| 042 | Scientific and technological services, consultancy and research, in particular in the field of medicine, medical diagnostics, pharmacy, molecular biology, biotechnology, immunology and genetics, for medicine development and for manufacturing medicines and pharmaceuticals; scientific and industrial research and development, in particular in the fields of medicine, medical diagnostics, pharmacy, molecular biology, biotechnology, immunology and genetics, for development of medicines and for the manufacture of medicines and pharmaceuticals; investigation and development of medicines, diagnostic and analysis agents and therapy procedures (medical research); pharmaceutical, genealogical, bacteriological, biological, biochemical, chemical, molecular biological and forensic laboratories (other than medical consultancy); scientific experiments and providing scientific expertise in the fields of medicine, medical diagnostics, pharmacy, molecular biology, biotechnology, immunology and genetics, for development of medicines and for the manufacture of medicines and pharmaceuticals; providing of technical information relating to generic medicines; services in relation to and advice on product development and quality maintenance; services of a medical and veterinary laboratory, in particular testing of medicines for others, development of new medicines; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Technical consulting in the field of pharmaceutical studies; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Pharmaceutical research services; pharmaceutical research and development; Technical research in the field of pharmaceutical studies; Research and development in the pharmaceutical and biotechnology fields; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Development of pharmaceutical preparations and medicines; pharmaceutical products development; pharmaceutical drug development services; Medical and scientific research, namely, conducting clinical trials for others; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals; conducting clinical trials for others; Consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and clinical trials; design and testing for new product development; chemical laboratories; Scientific and technological services, namely, scientific research, analysis, testing in the fields of pharmaceutical and drug development; scientific investigations for medical purposes; quality control for others; pharmaceutical drug development services; consultation in the private label manufacture and custom manufacture of pharmaceuticals and drugs | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 24, 2023 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 31, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 31, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 10, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 31, 2022 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 31, 2022 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 23, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 23, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 17, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 17, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 17, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 27, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 26, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 26, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 5, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 14, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 25, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 25, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 6, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 5, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 27, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 30, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 26, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 22, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |